Delivery Order SPE2DB22D2211-SPE2DB24FMKL4

Award Date 12/18/23
Potential Completion Date 12/19/23
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,540.73 firm fixed price delivery order is for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.82 firm fixed-price delivery order is for the supply of 4566680655 - TELMISARTAN 80 MG TABLET 30S, with a performance period ending on December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,472.24 firm-fixed-price delivery order is for the supply of 4562344660 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of September 29, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,669.19 firm fixed-price delivery order is for the supply of 4564847169 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,808.12 firm fixed price delivery order is for the supply of 4560714995 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,299.84, is for the delivery of 4566817262 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. This contract is a delivery order under an Indefinite Delivery Contract (IDC)...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,426.36 firm fixed-price delivery order is for the supply of 4567027950 - TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.70 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.30 Delivery Order contract is for the supply of 4560664400 TELMISARTAN 80 MG TABLET 30S. The contract has an ultimate completion date of April 21, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,590.05 firm fixed-price delivery order is for the supply of 4566371858 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FMKL4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,004.26 firm-fixed-price delivery order is for the supply of 4563134465 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of December 19, 2023.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued against that larger IDC contract. The contract award did not utilize any set-aside designation, indicating open competition.

Generated 5/13/25, 10:24 AM